Surfactant replacement therapy in extremely low gestational age newborns

Area of Science:

• Neonatal Medicine
• Respiratory Physiology
• Pediatric Critical Care

Background:

• Continuous positive airway pressure (CPAP) is increasingly recognized as a primary ventilatory support for extremely low gestational age newborns.
• Early rescue surfactant therapy demonstrates comparable efficacy to prophylactic administration.
• Novel surfactant administration techniques are emerging for neonatal respiratory support.

Purpose of the Study:

• To evaluate the efficacy and safety of the Intubation Surfactant Extubation (ISE) procedure.
• To assess the potential benefits of surfactant administration via a thin endotracheal catheter during spontaneous breathing with CPAP.
• To review current recommendations for surfactant therapy in extremely premature infants.

Main Methods:

• Review of current literature on neonatal respiratory support strategies.
• Analysis of short-term outcomes associated with less invasive surfactant administration.
• Discussion of the Intubation Surfactant Extubation (ISE) procedure as a combined therapy.

Main Results:

• The Intubation Surfactant Extubation (ISE) procedure may combine the benefits of surfactant therapy and early CPAP.
• Less invasive surfactant administration via a thin catheter during CPAP shows short-term advantages.
• Current evidence does not support general recommendation of this less invasive technique for vulnerable neonates.

Conclusions:

• Long-term follow-up studies are essential to establish definitive recommendations for surfactant therapy in extremely premature infants.
• Further research is needed to validate the long-term efficacy and safety of novel surfactant administration methods.
• Optimizing respiratory support and surfactant delivery remains a critical area in neonatal intensive care.